Renata O. Smith
Clinical Assistant Professor, Pharmacy Practice
Contact
Address:
833 S.Wood St, M/C 886, Chicago, IL
Office Phone:
Email:
Related Sites:
About Heading link
Research Interests:
HIV/HCV/PrEP/Gender affirming Care/Transitions of care
Teaching and Supervision Heading link
ISTP Didactics, 4/9/2024 – 4/23/2024
ISTP Didactics, 4/2/2024 – 4/23/2024
PHAR 506 Infectious Diseases, 1/8/2024 – Present
PMPR 349 Case Based Infectious Diseases, 1/8/2024 – 5/6/2024
Case Based Infectious Diseases (PMPR 349), 1/8/2024 – 4/26/2024
Case Based Infectious Diseases (PMPR 349), 1/8/2024 – 5/6/2024
338, 8/22/2023 – 12/12/2023
Management of the HIV Patient (PMPR 338), 8/21/2023 – 12/1/2023
Management of the HIV Patient (PMPR 338), 8/21/2023 – 12/15/2023
Selected Grants
CDPH Linkage to Care and Treatment, City of Chicago Department of Public Health., 4/30/2024 - Present, Obligated Amount: $250000; No Anticipated Amount Set
21S Design for the margins, Health Resources and Services Administration., 1/2/2023 - 12/31/2024, Obligated Amount: $82755; No Anticipated Amount Set
Using Innovative Interventions to Improve Health Outcomes Among People with HIV, he Fenway Institute and AIDS United., 6/1/2022 - Present, No Obligated Amount Set; No Anticipated Amount Set
USTART, HRSA., 7/6/2020 - 12/31/2024, No Obligated Amount Set; No Anticipated Amount Set
CRRT Service Contract, Chicago Department of Public Health., 7/1/2020 - 3/31/2022, Obligated Amount: $1000000; No Anticipated Amount Set
Merck Investigator Initiated Studies Program, Merck & Co., Inc.., 10/2019 - 12/31/2024, Obligated Amount: $125941.25; No Anticipated Amount Set
Merck Investigator Initiated Studies Program, Merck & Co., Inc.., 10/2019 - 12/31/2024, Obligated Amount: $125941.25; No Anticipated Amount Set
ASHP Foundation Pharmacy Resident Practice-Based Research Grant., 1/2016 - 11/2017, Obligated Amount: $5000; No Anticipated Amount Set
Pharmacist-Led Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PrEP) Clinic, Amer Soc of Health-Systems Pharmacists Fdn., 12/1/2015 - 11/30/2017, Obligated Amount: $5000; Anticipated Amount: $5000
Selected Publications
Guzman, Miriam, Smith, Renata, Mayer, Stockton, Messmer, Sarah, Huyck, Michael, Cotler, Karen F, Chaisson, Lelia H, Jimenez, Antonio, Guerrero, Stephanie, Fortson, Neisha, Tai, Rex. (2022). 1242. Hepatitis C Treatment as a Complement to Syringe Service Programs: Pilot Progress and Pathways Forward. Open Forum Infectious Diseases, 9, (Supplement_2), ofac492.1073. doi:10.1093/ofid/ofac492.1073.
Januszka, Jenna, Drwiega, Emily N, Drwiega, Emily N, Burgos, Rodrigo M, Michienzi, Sarah M, Smith, Renata, Badowski, Melissa E. (2022). 2060. Evaluation of the real world incidence of integrase inhibitor resistance since adoption as guideline preferred therapy. Open Forum Infectious Diseases, 9, (Supplement_2), ofac492.1682. doi:10.1093/ofid/ofac492.1682.
Lee, Clara, Sapasap, Jenna, LaRochelle, Joseph, Smith, Renata O, Badowski, Melissa E. (2021). Antiretroviral Therapy in Children and Adolescents: A Look Into Modern Single Tablet Regimens.. The Journal of Pediatric Pharmacology and Therapeutics, 26, (8), 783-794. doi:10.5863/1551-6776-26.8.783.
Badowski, Melissa E, Britt, Nicholas, Huesgen, Emily C, Lewis, Michelle M, Miller, Misty M, Nowak, Kathleen, Sherman, Elizabeth, Smith, Renata O. (2021). Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 41, (3), 299-314. doi:10.1002/phar.2499.
Brizzi, Marisa B, Burgos, Rodrigo M, Chiampas, Thomas D, Michienzi, Sarah M, Smith, Renata, Yanful, Paa Kwesi, Badowski, Melissa E. (2020). Impact of Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Interventions on Persons With Human Immunodeficiency Virus. Open Forum Infectious Diseases, 7, (8), ofaa073. doi:10.1093/ofid/ofaa073.
Brizzi, Marisa B, Burgos, Rodrigo M, Chiampas, Thomas D, Michienzi, Sarah M, Smith, Renata, Badowski, Melissa E. (2019). 1309. Effects of a Pharmacist-Driven Antiretroviral Stewardship and Transitions of Care Service in Persons Living with HIV/AIDS. Open Forum Infectious Diseases, 6, (Supplement_2), s471-s472. doi:10.1093/ofid/ofz360.1172.
Michienzi, Sarah, Burgos, Rodrigo, Smith, Renata, Martin, Michelle. (2018). 2236. Direct-Acting Antivirals: Efficacy in a Real-World, Urban, Undeserved, HIV-HCV Co-Infected Population. Open Forum Infectious Diseases, 5, (suppl_1), s661-s662. doi:10.1093/ofid/ofy210.1889.
Smith, RO, Michienzi, Sarah. (2018). HIV PrEP: Role of the Clinical Pharmacist. HIV Specialist. .
Huesgen, Emily, DeSear, Kathryn E, Egelund, Eric F, Smith, Renata, Max, Blake, Janelle, Jennifer. (2016). A HAART‐Breaking Review of Alternative Antiretroviral Administration: Practical Considerations with Crushing and Enteral Tube Scenarios. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 36, (11), 1145-1165. doi:10.1002/phar.1835.
Professional Leadership
Interdisciplinary mentoring, UIHealth, 1/3/2022 - 12/17/2021
AFC Medical Advisory Group Chicago, 1/3/2022 - Present
CRRT COVID Vaccination, Chicago department of public health, 3/1/2021 - 12/31/2021
UI Health World AIDS Day, UIC, 10/2/2020 - 12/6/2019
Elections Society of Infectious Diseases Pharmacists, 10/1/2020 - 10/1/2014
Gender Affirming Care Clinic Development, UI Health, 5/3/2019 - Present
GPPA Honors College Admissions, UIC, 1/5/2018 - 10/4/2019
SIDP Membership Application, SIDP, 10/1/2012 - 5/1/2018
Education
Degrees:
Pharm.D, University of Illinois at Peoria, United States, 1996
Postgraduate Training:
PGY1, UIC, United States, 1997
ID PGY2, UIHealth, United States, 1998